Schedule 13G ownership disclosure
Eleven Biotherapeutics, Inc.
Security class unavailable
Event date: 2016-05-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-16-602420
- Form type
- SC 13G
- Filer
- Boxer Capital, LLC
- CIK
- CIK 1465837
- Filed
- May 25, 2016
- Reporting period
- May 16, 2016
- Description
- Schedule 13G beneficial ownership